Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.
Valério-Fernandes Â, Fonseca NA, Gonçalves N, Cruz AF, Pereira MI, Gregório AC, Moura V, Ladeirinha AF, Alarcão A, Gonçalves J, Abrunhosa A, Melo JB, Carvalho L, Simões S, Moreira JN. Valério-Fernandes Â, et al. Among authors: gregorio ac. Cancers (Basel). 2022 Apr 29;14(9):2217. doi: 10.3390/cancers14092217. Cancers (Basel). 2022. PMID: 35565346 Free PMC article.
Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
Fonseca NA, Rodrigues AS, Rodrigues-Santos P, Alves V, Gregório AC, Valério-Fernandes Â, Gomes-da-Silva LC, Rosa MS, Moura V, Ramalho-Santos J, Simões S, Moreira JN. Fonseca NA, et al. Among authors: gregorio ac. Biomaterials. 2015 Nov;69:76-88. doi: 10.1016/j.biomaterials.2015.08.007. Epub 2015 Aug 6. Biomaterials. 2015. PMID: 26283155
Meeting the needs of breast cancer: A nucleolin's perspective.
Gregório AC, Lacerda M, Figueiredo P, Simões S, Dias S, Moreira JN. Gregório AC, et al. Crit Rev Oncol Hematol. 2018 May;125:89-101. doi: 10.1016/j.critrevonc.2018.03.008. Epub 2018 Mar 21. Crit Rev Oncol Hematol. 2018. PMID: 29650282 Review.